ACCESS Newswire

ZeptoMetrix

16.5.2023 15:02:55 CEST | ACCESS Newswire | Press release

Share
ZeptoMetrix Launches PROtrol: Quality Control Material for the Lateral Flow Immunoassay Market

BUFFALO, NY / ACCESSWIRE / May 16, 2023 / ZeptoMetrix® is excited to introduce PROtrol TM, a new line of products designed for antigen-based diagnostic methods. These third-party materials mimic a true clinical specimen and can be used to evaluate and monitor the performance of antigen-based assays, including lateral flow immunoassays for infectious diseases.

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
ZeptoMetrix logo



PROtrol is the only whole organism reference material to provide complete testing data. Each lot of product is supplied with the protein concentration and TCID50 value, which minimizes qualification testing. PROtrol provides better reproducibility, which optimizes the use of financial spending and processing time through the decreased need for repeat testing.

"The rapid expansion in development of antigen-based assays has highlighted some quality challenges. Inactivated, whole organism controls designed specifically for antigen tests can equip manufacturers with the tools they need to better evaluate the performance of their assays, leading to higher quality tests on the market," said Dr. Karuna Sharma, Vice President & Chief Scientific Officer.

PROtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Isolate: USA-WA1/2020* is the first member of this product line (PROSARS(COV2)-587). As we move beyond the COVID-19 pandemic, ZeptoMetrix will continue to grow the PROtrol product line, providing high-quality controls to assay manufacturers seeking to expand access to inexpensive and easy-to-use diagnostics.

"The launch and expansion of PROtrol enhances our position as the partner of choice for diagnostic test developers," said Evangeline Gonzalez, President of Antylia Diagnostics division. "As we work with our diagnostic partners, ZeptoMetrix is pleased with the role that PROtrol plays to give patients around the world more access to diagnostic testing."

More information on how to order the new PROtrol and additional ZeptoMetrix products can be found at: https://www.zeptometrix.com

About ZeptoMetrix®
ZeptoMetrix® is an established industry leader in the design, development, and delivery of innovative, quality solutions to the infectious disease diagnostics market. Our expertise and abilities in molecular diagnostics, including external quality controls, verification panels, proficiency panels, customized and OEM products/services have set the industry standard for performance and reliability and make ZeptoMetrix the preferred choice for independent third-party quality control materials.

Links:
* (PROSARS(COV2)-587): product page
https://www.zeptometrix.com/products/protrolt-sars-cov-2-isolate-usa-wa1-2020-1-ml

Contact Information

Andrew Zenger
Global Product Manager
andrew.zenger@antylia.com
(716) 715-7417

Related Files

PROSARS(COV2)-587 Product Insert.pdf
ZeptoMetrix Launches PROtrol.pdf

SOURCE: ZeptoMetrix

To view this piece of content from stats.newswire.com, please give your consent at the top of this page.

View source version on accesswire.com:
https://www.accesswire.com/755095/ZeptoMetrix-Launches-PROtrol-Quality-Control-Material-for-the-Lateral-Flow-Immunoassay-Market

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

GTDC Highlights Distributors' Vital Role in Scaling AI Adoption and Digital Transformation15.4.2026 15:00:00 CEST | Press release

Industry leaders stress that digital platforms, support, and collaboration are essential to boost sales, engage channels, and respond to shifts in global trade, workforce shortages, and the rise of robotics and AI. Technology distribution is evolving as these "AI-first" partners emerge, developing and deploying original AI solutions that define a new era of applied AI. IT distributors help speed up cloud, AI, and emerging tech adoption by investing in advanced systems and services for vendors and solution providers. NOORDWIJK, NL / ACCESS Newswire / April 15, 2026 / IT distributors have become a driving force behind the sales and adoption of AI, advanced cloud and cybersecurity solutions and other next‑generation technologies based on research and discussions at this week's GTDC Summit EMEA conference. The quickly evolving digital landscape was a central theme of the annual channel executive event, hosted by the Global Technology Distribution Council (GTDC), the world's largest consort

GTDC Highlights Distributors' Vital Role in Scaling AI Adoption and Digital Transformation15.4.2026 15:00:00 CEST | Press release

Industry leaders stress that digital platforms, support, and collaboration are essential to boost sales, engage channels, and respond to shifts in global trade, workforce shortages, and the rise of robotics and AI. Technology distribution is evolving as these "AI-first" partners emerge, developing and deploying original AI solutions that define a new era of applied AI. IT distributors help speed up cloud, AI, and emerging tech adoption by investing in advanced systems and services for vendors and solution providers. NOORDWIJK, NL / ACCESS Newswire / April 15, 2026 / IT distributors have become a driving force behind the sales and adoption of AI, advanced cloud and cybersecurity solutions and other next‑generation technologies based on research and discussions at this week's GTDC Summit EMEA conference. The quickly evolving digital landscape was a central theme of the annual channel executive event, hosted by the Global Technology Distribution Council (GTDC), the world's largest consort

Innodata to Report First Quarter 2026 Results15.4.2026 14:00:00 CEST | Press release

NEW YORK CITY, NY / ACCESS Newswire / April 15, 2026 / INNODATA INC. (Nasdaq:INOD) today announced that it will report First Quarter 2026 results after the market closes on Thursday, May 7, 2026. A news release will be available in both the News and Investor Relations sections of the Innodata website, www.innodata.com. Innodata has scheduled an investor conference call for 5:00 PM Eastern time on that same day. The call-in numbers for the conference call are: (+1) 800 715 9871 North America, Toll Free (+44) 800 358 0970 United Kingdom (+1) 646 307 1963 International Participant Access Code 3150581 For Replay: (+1) 800 770 2030 North America-Toll Free (+1) 609 800 9909 International Playback ID 3150581 Investors are also invited to access a live Webcast of the conference call at the Investor Relations section of Innodata's website at https://investor.innodata.com/events-and-presentations/. Please note that the Webcast feature will be in listen-only mode. Call-in replay will be available

Innodata to Report First Quarter 2026 Results15.4.2026 14:00:00 CEST | Press release

NEW YORK CITY, NY / ACCESS Newswire / April 15, 2026 / INNODATA INC. (Nasdaq:INOD) today announced that it will report First Quarter 2026 results after the market closes on Thursday, May 7, 2026. A news release will be available in both the News and Investor Relations sections of the Innodata website, www.innodata.com. Innodata has scheduled an investor conference call for 5:00 PM Eastern time on that same day. The call-in numbers for the conference call are: (+1) 800 715 9871 North America, Toll Free (+44) 800 358 0970 United Kingdom (+1) 646 307 1963 International Participant Access Code 3150581 For Replay: (+1) 800 770 2030 North America-Toll Free (+1) 609 800 9909 International Playback ID 3150581 Investors are also invited to access a live Webcast of the conference call at the Investor Relations section of Innodata's website at https://investor.innodata.com/events-and-presentations/. Please note that the Webcast feature will be in listen-only mode. Call-in replay will be available

Envision Pharma Group Strengthens Executive Leadership Team to Accelerate Growth, Innovation and Global Client Delivery15.4.2026 14:00:00 CEST | Press release

Two Senior Appointments Reinforce Commitment to Technology Integration and Scalable Pharmaceutical Services FAIRFIELD, CT / ACCESS Newswire / April 15, 2026 / Envision Pharma Group (Envision), a global, technology-enabled solutions partner to the life sciences industry, has appointed two senior executives to further strengthen its leadership team and focus on integrating innovative AI technologies across its portfolio to deliver more data-driven outcomes for clients. Jay Ferro has been appointed President, Technology and Chief Product Officer. He joins Envision from Clario, a global clinical trial endpoint and technology company, where he led platform modernization and operational transformation initiatives that helped position the company for its acquisition in October 2025. Ferro will oversee a combined technology and product organization responsible for shaping enterprise technology strategy, translating business needs into scalable product solutions, and ensuring investments align

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye